Scott Schlackman
CIK: 0001645617
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MED
MEDIFAST INC
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 26, 2026MED
MEDIFAST INC
Award(A)Direct11.7K shares- - May 11, 2026MED
MEDIFAST INC
Purchase(P)Direct2.5K shares at avg. $12.53$31K - May 8, 2026MED
MEDIFAST INC
Purchase(P)Direct2.5K shares at avg. $12.65$32K - Jun 25, 2025MED
MEDIFAST INC
Award(A)Direct11.2K shares-
1-4 of 4 transactions
About SCHLACKMAN SCOTT
SCHLACKMAN SCOTT (SEC CIK 0001645617) files insider reports with the SEC as Director of MEDIFAST INC (MED).
Signal8 holds 3 ownership filings by SCHLACKMAN SCOTT, all Form 4s, filed between Jun 26, 2025 and May 28, 2026. Those filings report 4 transactions, from Jun 25, 2025 to May 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SCHLACKMAN SCOTT's filings is in BALTIMORE, MD.
Recent filings by SCHLACKMAN SCOTT
Other insiders filing for MEDIFAST INC (MED)
- Kiai Parsa, Director
- Rose Jeffrey Matthew, Director
- Thomas Andrea B, Director
- Geary Elizabeth A., Director
- Xian Ming, Director
- Johnson Nicholas Mark, President